Polar Asset Management Partners Inc. Invests $945,000 in Inspire Medical Systems, Inc. (NYSE:INSP)

Polar Asset Management Partners Inc. acquired a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 5,100 shares of the company's stock, valued at approximately $945,000.

A number of other institutional investors also recently modified their holdings of INSP. Merit Financial Group LLC acquired a new stake in Inspire Medical Systems in the 4th quarter valued at about $313,000. Nisa Investment Advisors LLC lifted its holdings in Inspire Medical Systems by 37.3% during the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company's stock worth $68,000 after buying an additional 100 shares in the last quarter. SG Americas Securities LLC boosted its position in Inspire Medical Systems by 33.8% in the 4th quarter. SG Americas Securities LLC now owns 3,534 shares of the company's stock valued at $655,000 after buying an additional 892 shares during the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Inspire Medical Systems by 248.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 4,806 shares of the company's stock valued at $891,000 after buying an additional 3,427 shares during the period. Finally, Riverbridge Partners LLC acquired a new stake in shares of Inspire Medical Systems in the 4th quarter valued at $26,342,000. Institutional investors own 94.91% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Truist Financial decreased their price target on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a report on Tuesday, February 11th. KeyCorp reduced their price objective on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Stifel Nicolaus reduced their price target on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Royal Bank of Canada cut their target price on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Finally, JPMorgan Chase & Co. cut their price target on shares of Inspire Medical Systems from $235.00 to $195.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Inspire Medical Systems has a consensus rating of "Moderate Buy" and a consensus price target of $211.91.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 360 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $160.00, for a total transaction of $57,600.00. Following the transaction, the director now owns 24,046 shares of the company's stock, valued at $3,847,360. The trade was a 1.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Stock Down 2.5%

Shares of INSP traded down $3.69 on Wednesday, hitting $146.36. The company's stock had a trading volume of 342,489 shares, compared to its average volume of 558,449. The firm has a market capitalization of $4.32 billion, a price-to-earnings ratio of 84.60, a P/E/G ratio of 2.86 and a beta of 1.39. The firm's fifty day moving average price is $155.03 and its 200-day moving average price is $176.18. Inspire Medical Systems, Inc. has a fifty-two week low of $123.00 and a fifty-two week high of $225.00.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.33. The business had revenue of $201.32 million for the quarter, compared to analyst estimates of $194.89 million. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. Inspire Medical Systems's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.34) EPS. As a group, equities analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.